Related Experiment Videos
Immunogenicity and reactogenicity of new multivalent pneumococcal vaccines
Zentralblatt Fur Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten Und Parasitologie = International Journal of Microbiology and Hygiene. A, Medical Microbiology, Infectious
|April 1, 1982
Summary
This study evaluated the immunogenicity of pneumococcal polysaccharide vaccines. All tested vaccines demonstrated satisfactory immunogenicity and were well tolerated in healthy adults.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Pneumococcal polysaccharide vaccines are crucial for preventing infections caused by Streptococcus pneumoniae.
- Developing multivalent vaccines with broader serotype coverage is an ongoing area of research.
Purpose of the Study:
- To assess the immunogenicity and tolerability of different valencies of pneumococcal polysaccharide vaccines.
- To evaluate the immune response to specific serotypes included in the investigational vaccines.
Main Methods:
- A two-phase study involving healthy adult volunteers.
- Administration of tetravalent (1, 3, 4, 12F), tetravalent (14, 18C, 19F, 23F), and pentadecavalent (1-23F) pneumococcal polysaccharide vaccines.
- Placebo control group under single-blind conditions.
Main Results:
- All tested pneumococcal polysaccharide vaccines were well tolerated with transient local reactions in a small number of subjects.
- The study indicated that all 15 polysaccharides included in the vaccines were satisfactorily immunogenic.
- Encouraging preliminary results suggest the potential for broader serotype coverage.
Conclusions:
- The evaluated pneumococcal polysaccharide vaccines show promising immunogenicity and good tolerability in healthy adults.
- Further research is warranted to explore the reactogenicity and immunogenicity of pneumococcal vaccines with even greater serotype diversity.